export const QUESTION_BANK_DATA = {
  pharmacology: {
    name: "Pharmacology",
    subtopics: {
      "general-pharmacology": {
        name: "General Pharmacology",
        subtopics: {
          essay: {
            name: "Essay",
            questions: [
              "Biotransformation ** (Aug 14;Feb 10) (Pg.No: 28)\nDiscuss:\n- Biotransformation Reactions, Phase I and Phase II reaction with suitable examples\n- Importance of Enzyme Induction and Enzyme Inhibition\n- Microsomal Enzyme Induction and Inhibition with examples\n\nProbable Case:\nA 35 year old woman taking combined oral contraceptive pills was diagnosed with tuberculosis and put on isoniazid, rifampicin, pyrazinamide, and ethambutol combination therapy for 2 months followed by isoniazid and rifampicin thrice weekly for 4 months. In the 3rd month of treatment, she failed to have withdrawal bleeding during the gap period of contraceptive cycle. One week later her urinary pregnancy test was found to be positive.",
              "Factors Modifying Drug Action ** (Aug 15;Aug 10) (Pg.No: 73)\nDiscuss:\n- Definition Drug and Dose\n- Various Factors Modifying a Drug's Actions\n- Note about Pharmacogenetics",
              "Routes of Drug Administration (Apr 01) (Pg.No: 9)\nExplain:\n- Each Route of Administration\n- Examples\n- Advantages and Disadvantages"
            ]
          },
          "short-note": {
            name: "Short Note",
            questions: [
              "Biological Half Life (or) Plasma Half Life ****** (Jul 23;Aug 18;Feb 17;Aug 05;Mar 02;Nov 95) (Pg.No: 39)\n- Drugs with short half-life\n- Drugs with long and very short half life",
              "Drug Tolerance (Tachyphylaxis) ****** (Feb 23;Feb 22;Aug 17;Feb 09;Mar 02;Apr 97) (Pg.No: 80)",
              "Pharmacogenetics ****** (Feb 23;Sep 21;Aug 17;Feb 09;Feb 08;Apr 01) (Pg.No: 75)",
              "Pharmacovigilance ****** (Aug 22;Mar 22;Sep 21;Feb 18;Feb 16;Aug 13) (Pg.No: 93)",
              "Newer Drug Delivery System ***** (Feb 23;Feb 13;Feb 11;Feb 08;Nov 94) (Pg.No: 42)",
              "Bioavailability **** (Feb 20;Aug 09;Aug 04;Apr 01) (Pg.No: 22)",
              "First Pass Metabolism (Pre-Systemic Elimination) **** (Aug 16;Feb 07;Oct 98;Jan 93) (Pg.No: 34)",
              "Drug Antagonism *** (Feb 12;Feb 05;Nov 01) (Pg.No: 67)",
              "Sublingual Route of Drug Administration *** (Aug 11;Aug 08;Oct 97) (Pg.No: 12)",
              "Teratogenicity *** (Aug 22;Feb 19;Nov 01) (Pg.No: 99)",
              "Biotransformation ** (Aug 08;Apr 99) (Pg.No: 28)",
              "Microsomal Enzyme Inducers ** (Feb 23;Feb 12) (Pg.No: 33)",
              "Phase 2 Biotransformation Reactions with Suitable Examples ** (Mar 22;Feb 20) (Pg.No: 31)",
              "Phase III Clinical Trial ** (Feb 22;Feb 19) (Pg.No: 91)",
              "Post Marketing Surveillance During Newer Drug Development (Phase IV Clinical Trial) ** (Feb 17;Nov 95) (Pg.No: 91)",
              "Prolongation Of Drug Action ** (Jul 23;Apr 96) (Pg.No: 42)",
              "Protein Binding of Drugs ** (Sep 21;Oct 03) (Pg.No: 25)\n- Clinical significance with Examples",
              "Therapeutic Index ** (Aug 07;Oct 96) (Pg.No: 65)",
              "Transdermal Application Of Drugs ** (Feb 22;Oct 00) (Pg.No: 12)",
              "Blood Brain Barrier (Aug 11) (Pg.No: 24)",
              "Causality Assessment (Aug 22) (Pg.No: 93)",
              "Drug Receptor (Oct 00) (Pg.No: 48)",
              "Drug Responses in Elderly (Aug 12) (Pg.No: 74)",
              "Drug Synergism (Feb 16) (Pg.No: 66)",
              "Drugs in Anaphylactic Shock (Pg.No: 97)",
              "Essential Drugs (Feb 12) (Pg.No: 6)",
              "Fixed Dose Ratio Combination (Feb 13) (Pg.No: 72)",
              "Iatrogenicity (Oct 00) (Pg.No: 101)",
              "Intracellular Receptors (Nov 20) (Pg.No: 60)",
              "Local Routes Of Drug Administration (Feb 10) (Pg.No: 10)",
              "Orphan Drugs (Aug 18) (Pg.No: 7)",
              "Parenteral Route of Drug Administration (Aug 19) (Pg.No: 13)",
              "Pharmacokinetics (Pg.No: 15)",
              "Phase 1 Biotransformation Reaction with Examples (Aug 06) (Pg.No: 29)",
              "Physical Antagonism (Nov 20) (Pg.No: 67)",
              "Prodrug (Aug 04) (Pg.No: 28)",
              "Receptor Antagonism (Aug 11) (Pg.No: 68)",
              "Rectal Route of Administration (Dec 23) (Pg.No: 12)",
              "Specialized Active Transport Mechanism Across Biological Membrane (Aug 13) (Pg.No: 18)",
              "Zero Order Pharmacokinetics (Aug 19) (Pg.No: 38)"
            ]
          }
        }
      },
      "autonomic-nervous-system": {
        name: "Autonomic Nervous System",
        subtopics: {
          essay: {
            name: "Essay",
            questions: [
              "Beta-Blockers ******* (Feb 23;Aug 16;Feb 12;Feb 07;Aug 04;Mar 02;Oct 00) (Pg.No: 157)\nDiscuss:\n- Classification, Pharmacological Effects, Uses, Adverse Effects\n- Drug receptor, Enumerate Beta Blockers, Adverse effects and Contraindications of Non Cardio Selective Beta Blockers\n- Mechanism of action of Proponalol, Pharmacological Action of Proponalol, Therapeutic uses of Proponalol\n- Therapeutic uses, Advantages of cardio Selective Beta Blockers\n- Role of Beta Blockers in Thyrotoxicosis",
              "Adrenaline ***** (Feb 13;Feb 11;Feb 09;Aug 05;Feb 05) (Pg.No: 136)\nDiscuss:\n- Classification of Sympathomimetics, Cardiovascular Action, Therapeutic Uses, Adverse Effects\n- Mechanism of Action, Contraindications",
              "Atropine ** (Aug 09;Aug 07) (Pg.No: 124)\nExplain:\n- Classification of Anti-Cholinergic drugs, Therapeutic Action, Adverse Effects, Contraindications, Managements of Atropine Poisoning\n- Atropine Derivatives and Their Uses",
              "Anti-Cholinersterases (Aug 13;Aug 11) (Pg.No: 116)\nDiscuss:\n- Mechanism of Action, Indication of Reversible Anti-Cholinersterases, Management of Acute Organophosphorus Poisoning",
              "Muscarinic Receptor Blockers (Oct 00) (Pg.No: 124)\nExplain:\n- Natural and Synthetic drugs, Action on Eye and Smooth Muscles with Indications, Systemic Adverse Effects",
              "Organo Phosphorus Compound poisoning (Feb 21) (Pg.No: 122)\nDiscuss:\n- Antidote, Receptor antagonism with suitable diagrams, Cholinergic crisis in Myasthenia Gravis"
            ]
          },
          "short-note": {
            name: "Short Note",
            questions: [
              "Beta-Blockers ****** (Aug 22;Sep 21;Aug 12;Aug 09;Feb 09;Aug 08;Mar 02;Jan 93) (Pg.No: 160)\n- Therapeutic uses, Contraindications\n- Indications, Contraindications, Extra-Cardiac Uses\n- Adverse Effects",
              "Anti-Glaucoma Drugs ***** (Aug 18;Aug 16;Aug 13;Feb 11;Feb 09) (Pg.No: 153)",
              "Management of Organo Phosphorus Poisoning ***** (Feb 23;Dec 19;Feb 17;Feb 15;Aug 10;Aug 08) (Pg.No: 122)\n- Cholinesterase Reactivators",
              "Alpha Adrenergic Blockers **** (Aug 18;Aug 16;Feb 12;Aug 10;Feb 09;Oct 02) (Pg.No: 153)\n- Therapeutic Uses",
              "Drugs for Glaucoma **** (Feb 10;Feb 05;Oct 02;Oct 96) (Pg.No: 165)",
              "Timolol *** (Feb 18;Aug 09;Dec 90) (Pg.No: 167)\n- Rationale for use in the treatment of Glaucoma",
              "Atropine ** (Jul 23;Feb 14) (Pg.No: 124)\n- Pharmacological action, Uses, Substitutes",
              "Dopamine in Cardiogenic Shock ** (Feb 10;Aug 09) (Pg.No: 146)",
              "Drugs used in Open Angle Glaucoma ** (Aug 22;Aug 19) (Pg.No: 166)",
              "Therapeutic uses of Adrenergic Drugs ** (Mar 22;Feb 14) (Pg.No: 150)",
              "Adrenaline (Aug 17) (Pg.No: 136)",
              "Beta Stimulants (Nov 95) (Pg.No: 149)",
              "Cholinergic Crisis (Aug 14) (Pg.No: 121)",
              "Clonidine (Aug 12;Aug 04) (Pg.No: 611)\n- Extravascular Uses",
              "Labetalol (Feb 19) (Pg.No: 165)\n- Uses, Adverse Effects",
              "Proponalol (Aug 04) (Pg.No: 157)",
              "Therapeutic Uses of Atropine (Aug 06) (Pg.No: 130)",
              "Treatment for Benign Prostatic Hypertrophy (BPH) (Jul 23) (Pg.No: 157)\n- Preferred drugs, Rational in using them",
              "Treatment of Myasthenia Gravis (Oct 03) (Pg.No: 120)",
              "Uroselective Alpha Adrenergic Blockers (Aug 12) (Pg.No: 156)"
            ]
          }
        }
      },
      "central-nervous-system": {
        name: "Central Nervous System",
        subtopics: {
          essay: {
            name: "Essay",
            questions: [
              "Anti-Epileptic Drugs ********** (Aug 22;Nov 20;Feb 18;Aug 14;Feb 12;Aug 10;Feb 10;Feb 08;Aug 04;Mar 02;Apr 01;Oct 00;Apr 98;Apr 96) (Pg.No: 438)\nDiscuss:\n- Classify Anticonvulsant drugs\n- Mechanism of Action, Pharmacological Action, Uses, Adverse effects of Benzodiazepines\n- Treatment of Febrile Seizures\n- Pharmacology of Topiramate\n- How will you manage a known epileptic patient with three months of amenorrhea\n- Pharmacology of drugs acting on GABA receptors\n- Mechanism of Action, Uses, Adverse Effects, Therapeutic Indications, Interactions of Diphenyl Hydantoin, Phenytoin\n- Mechanism of Action, Uses, Adverse Effects of Drugs Used in Absence Seizures\n- Mechanism of Action, Pharmacological Action, Uses, Adverse Effects of Valproate\n- Management of Status Epilepticus\n\nProbable Cases:\n- A 25 year old lady is brought with complaints of recurrent episodes of fits lasting for 2-3 minutes. She experience aura before each episode. Description of fit by husband corresponds to generalized tonic clonic seizure.\n- A 8 year old boy was sent for neurological evaluation because of episodes of apparent inattention. His mother gives history of episodes of starring look which lasts for few seconds and he immediately resumes his previous activity. Diagnosed with absence seizures.\n- A 45 year old male patient is brought to EM with c/o seizure episode associated with loss of consciousness. He is known epileptic for past 2 years with h/o recurrent tonic clonic seizures.",
              "Anti-Parkinsonism ***** (Mar 22;Aug 17;Aug 13;Feb 13;Apr 92) (Pg.No: 452)\nDiscuss:\n- Classify Anti-Parkinsonism drugs\n- Write about Dopaminergic Agonists\n- Mechanism of Action, Pharmacological Action, Adverse Effects, Interactions of Levodopa\n- What is the Rationale for use of Carbidopa with Levodopa\n- Write about Selegeline\n\nProbable Cases:\n- A 65 year old male on antipsychotics medication came with c/o difficulty in walking, resting tremors and difficulty in swallowing.",
              "Opioids **** (Jul 23;Feb 07;Apr 00;Apr 00) (Pg.No: 497)\nDiscuss:\n- Enumerate drugs acting on opioid receptors\n- Mechanism of Action, Pharmacological Action, Uses, Adverse Effects, Contraindications of Morphine\n- Clinical Features of Acute Morphine Poisoning and Treatment\n- Classification of Opioid analgesics\n- Opioid Antagonists",
              "Sedatives and Hypnotics *** (Feb 16;Aug 11;Feb 05) (Pg.No: 424)\nDiscuss:\n- Enumerate Various Sedative and Hypnotic Drugs\n- Mechanism of Action, Uses, Adverse Effects of Benzodiazepines\n- Management of Acute Barbiturate Poisoning\n- Write briefly about Flumazenil\n- Write about Benzodiazepine overdose",
              "Anti-Depressants ** (Feb 19;Aug 01) (Pg.No: 481)\nDiscuss:\n- Classification of Anti-Depressants\n- Mechanism of Action, Uses, Adverse effects of Selective Serotonin Reuptake Inhibitors (SSRIs)\n- Difference between Fluoxetine and Imipramine",
              "Anti-Psychotic Drugs ** (Oct 03;Apr 99) (Pg.No: 463)\nDiscuss:\n- Classification\n- Mechanism of Action, Pharmacological Action, Preparations with Doses, Uses, Adverse Effects, Interactions of Chlorpromazine",
              "General Anaesthetics (Aug 04;Oct 03) (Pg.No: 400)\nDiscuss:\n- Classification, Stages, Merits and demerits of Halothane and Ether as an anaesthetic"
            ]
          },
          "short-note": {
            name: "Short Note",
            questions: [
              "Pre-Anaesthetic Medications ********** (Feb 23;Aug 22;Feb 18;Feb 14;Feb 12;Aug 10;Feb 10;Aug 09;Feb 08;Aug 05) (Pg.No: 413)",
              "Treatment of Methanol Poisoning ******** (Aug 16;Aug 13;Aug 12;Aug 11;Aug 10;Aug 09;Feb 09;Oct 03) (Pg.No: 422)\n- Rationale of using Ethanol\n- Rationale of using Fomepizole (ADH inhibitor)",
              "Atypical Anti-Psychotics Drugs ****** (Mar 22;Feb 20;Aug 15;Feb 12;Feb 09;Apr 00) (Pg.No: 468)\n- Difference between typical and atypical Anti-Psychotics",
              "Dissociative Anaesthesia ****** (Feb 22;Feb 19;Feb 18;Feb 10;Aug 04;Apr 00;Dec 90) (Pg.No: 411)\n- Ketamine",
              "Selective Serotonin Re-uptake Inhibitors (SSRIs) ****** (Aug 14;Feb 13;Feb 10;Aug 08;Feb 08;Aug 05) (Pg.No: 487)",
              "Benzodiazepines ***** (Jul 23;Feb 20;Aug 12;Feb 09;Oct 98) (Pg.No: 427)\n- Uses of Diazepam\n- Mechanism of Action, Uses, Adverse Effects",
              "Ketamine ***** (Feb 22;Feb 19;Aug 04;Apr 00;Dec 90) (Pg.No: 411)",
              "Status Epilepticus ***** (Aug 12;Feb 09;Feb 07;Oct 00;Apr 00) (Pg.No: 450)",
              "Morphine **** (Jul 23;Feb 23;Feb 14;Feb 12) (Pg.No: 498)\n- Mechanism of Action, Uses, Contraindications, Adverse Effects",
              "Pentazocine **** (Feb 13;Aug 08;Oct 03;Nov 93) (Pg.No: 510)",
              "Phenytoin Sodium **** (Feb 15;Feb 13;Feb 11;Apr 97) (Pg.No: 439)\n- Mechanism of Action, Pharmacokinetics, Uses, Adverse Effects, Interactions",
              "Selective Dopamine Agonist in Parkinsonism **** (Aug 22;Feb 19;Aug 12;Aug 10) (Pg.No: 457)",
              "Drug Therapy of Parkinsonism *** (Feb 15;Aug 09;Aug 08) (Pg.No: 452)",
              "Levodopa *** (Sep 21;Aug 19;Oct 97) (Pg.No: 457)\n- Rationale of using Carbidopa with Levodopa",
              "Neurolept Analgesia *** (Feb 23;Aug 09;Nov 01)",
              "Sodium Valproate *** (Feb 17;Feb 14;Nov 01) (Pg.No: 444)",
              "Newer Anti-Epileptic Drugs ** (Feb 23;Sep 21) (Pg.No: 446)",
              "Nitrous Oxide ** (Aug 19;Aug 91) (Pg.No: 405)",
              "Opioid Antagonists ** (Nov 20;Feb 05) (Pg.No: 511)",
              "Tramadol ** (Aug 18;Aug 16) (Pg.No: 504)",
              "Treatment of Alzheimer's ** (Sep 21;Feb 12) (Pg.No: 517)",
              "Advantages of Using Nitrous Oxide for General Anaesthesia (Aug 19) (Pg.No: 405)",
              "Anti-Anxiety Drugs (Aug 22) (Pg.No: 493)",
              "Atypical Anti-Depressants (Feb 22) (Pg.No: 490)\n- Mechanism of action, Uses",
              "Balance Anaesthesia (Feb 10)",
              "Carbamazepine (Feb 09) (Pg.No: 442)\n- Mechanism of Action, Uses, Adverse Effects, Interactions\n- Drugs used in Trigeminal Neuralgia",
              "Cheese Reaction (Jul 23) (Pg.No: 482)",
              "Chlorpromazine (Oct 00) (Pg.No: 463)",
              "Complications of General Anaesthesia (Feb 14) (Pg.No: 412)",
              "Conscious Sedation (Feb 19) (Pg.No: 412)",
              "Difference Between Buspirone and Benzodiazepine (Feb 20) (Pg.No: 495)",
              "Drug Interactions in Alcoholic (Feb 20) (Pg.No: 419)",
              "Drugs used in Smoking Cessation (Aug 22) (Pg.No: 492)",
              "Ether (Apr 92) (Pg.No: 405)",
              "Flumazenil (Jan 93) (Pg.No: 435)",
              "Intravenous General Anaesthesia (Aug 08) (Pg.No: 408)\n- Classification, Mechanism of Action, Uses, Adverse Effects",
              "Non-Benzodiazepine Hypnotic (Aug 10) (Pg.No: 432)",
              "Opioid Receptors (Aug 14) (Pg.No: 507)",
              "Propofol (Aug 12) (Pg.No: 409)",
              "Serotonin and Noradrenaline Re-uptake Inhibitors (SNRIs) (Aug 13) (Pg.No: 489)",
              "Serotonin Syndrome (Pg.No: 488)",
              "Thiopentone Sodium (Aug 11) (Pg.No: 408)",
              "Topiramate (Aug 13) (Pg.No: 447)",
              "Treatment of Alcohol Dependence (Jul 23) (Pg.No: 421)\n- Rationale of using Disulfiram",
              "Treatment of Barbiturate Poisoning (Apr 96) (Pg.No: 427)",
              "Tricyclic Anti-Depressants (TCA) (Feb 09) (Pg.No: 482)",
              "Uses of Lithium in Psychiatry (Oct 03) (Pg.No: 474)"
            ]
          }
        }
      },
      "cardiovascular-system": {
        name: "Cardiovascular System",
        subtopics: {
          essay: {
            name: "Essay",
            questions: [
              "Anti-hypertensive drugs ********** (Feb 20;Aug 19;Feb 11;Aug 08;Aug 07;Aug 05;Oct 97;Apr 96;Nov 93;Dec 90) (Pg.No: 605)\n– Mechanism of Action of Captopril, Pharmacological Action of Captopril, Therapeutic Uses of Captopril, Adverse Effects of Captopril\n– Mechanism of Action of Angiotensin Receptor Blockers, Therapeutic Uses of Angiotensin Receptor Blockers, Hypertensive Emergencies, Hypertensive Urgencies\n– Classification of Anti-hypertensive Drugs, Therapeutic Uses of Beta Blockers, Adverse Effects of Beta Blockers, Anti-hypertensive Avoided in Pregnancy\n– Classification of Anti-hypertensive Drugs, Management of Hypertensive Emergency, Management of Hypertensive Urgency, Anti-hypertensive Avoided in Pregnancy",
              "Anti-anginal Drugs ***** (Feb 23;Aug 22;Feb 22;Feb 17;Feb 14) (Pg.No: 584)\n– Classification of Anti-anginal Drugs, Mechanism of Action of Nitrates, Uses of Nitrates, Adverse Effects of Nitrates\n– Classification of Anti-anginal Drugs, Mechanism of Vascular Smooth Muscle Relaxant Effect of Nitrates, Therapeutic Uses of Nitrates, About Nicorandil\n– Classification of Anti-anginal Drugs, Mechanism of Action of Glyceryl Trinitrate, Adverse Effects of Glyceryl Trinitrate, Drug Therapy in Myocardial Infarction\n– Classification of Antianginal Drugs, Mechanism of Action of Glyceryl Trinitrate, Therapeutic Uses of Glyceryl Trinitrate\n– Classification of Anti-anginal Drugs, Mechanism of Action of Nitrates, Uses of Nitrates, Adverse Effects of Nitrates",
              "Diuretics **** (Mar 22;Feb 14;Feb 09;Aug 06) (Pg.No: 625)\n– Classification of Diuretics, Mechanism of Action of Furosemide, Pharmacological Action of Furosemide, Therapeutic Uses of Furosemide, Adverse Effects of Furosemide\n– Classification of Diuretics, Mechanism of Action of Furosemide, Therapeutic Uses of Furosemide, Complications of Furosemide\n– Classification of Diuretics, Mechanism of Action of High Ceiling Diuretics, Uses of High Ceiling Diuretics, Adverse Effects of High Ceiling Diuretics, Rationality in Combining High Ceiling Diuretics with ACE Inhibitors",
              "Anti-arrhythmic Drugs ** (Aug 18;Nov 01) (Pg.No: 573)\n– Classification of Anti-arrhythmic Drugs, Mechanism of Action of Amiodarone, Pharmacokinetics of Amiodarone, Clinical Uses of Amiodarone, Adverse Effects of Amiodarone",
              "Myocardial Infarction (Jul 23) (Pg.No: 602)\n– Drug Therapy in Myocardial Infarction, Classification of Hypolipidemic Drugs, Mechanism of Action of Statins, Uses of Statins, Adverse Effects of Statins"
            ]
          },
          "short-note": {
            name: "Short Note",
            questions: [
              "Heparin ********** (Mar 22;Nov 20;Aug 19;Feb 15;Aug 14;Aug 13;Feb 11;Aug 10;Aug 05;Aug 04;Apr 01;Apr 98;Jan 93) (Pg.No: 663)\n- Heparin vs Warfarin\n- Low Molecular Weight Heparin",
              "Furosemide ******** (Nov 20;Aug 19;Feb 16;Aug 15;Feb 11;Nov 01;Apr 01;Oct 97) (Pg.No: 626)",
              "High Ceiling Diuretics ******* (Feb 23;Aug 18;Feb 13;Aug 11;Aug 09;Aug 08;Apr 96) (Pg.No: 625)",
              "Spironolactone ******* (Jul 23;Feb 20;Aug 18;Feb 18;Aug 15;Aug 12;Aug 08) (Pg.No: 634)",
              "Fibrinolytics ****** (Jul 23;Feb 23;Aug 22;Sep 21;Feb 07;Apr 99) (Pg.No: 673)",
              "Thiazide Diuretics ****** (Aug 17;Feb 17;Aug 13;Aug 11;Aug 10;Oct 03) (Pg.No: 628)",
              "Anti-platelet Drugs ***** (Jul 23;Feb 23;Aug 17;Feb 15;Feb 10) (Pg.No: 676)",
              "Aspirin ***** (Jul 23;Feb 19;Feb 16;Aug 13;Feb 11) (Pg.No: 677)",
              "Congestive Heart Failure ***** (Feb 20;Feb 18;Aug 07;Aug 06;Mar 02) (Pg.No: 561)",
              "Digoxin ***** (Nov 20;Aug 16;Aug 12;Feb 12;Feb 09) (Pg.No: 556)",
              "Osmotic Diuretics ***** (Feb 14;Feb 12;Feb 10;Feb 08;Aug 04) (Pg.No: 637)",
              "Parenteral Iron Therapy ***** (Feb 23;Aug 22;Aug 19;Aug 11;Aug 04) (Pg.No: 649)\n- Iron Preparations\n- Uses",
              "Potassium Sparing Diuretics ***** (Aug 16;Feb 05;Mar 02;Nov 95;Jan 93) (Pg.No: 634)",
              "Angiotensin Converting Enzyme (ACE) Inhibitors **** (Aug 22;Sep 21;Oct 03;Nov 01) (Pg.No: 530)",
              "Calcium Channel Blockers **** (Aug 09;Feb 09;Feb 05;Nov 94) (Pg.No: 591)",
              "Potassium Channel Openers **** (Nov 20;Feb 19;Feb 13;Aug 06) (Pg.No: 598)",
              "Statins **** (Mar 22;Aug 16;Aug 10;Mar 02) (Pg.No: 683)",
              "Acetazolamide *** (Aug 22;Aug 14;Feb 14) (Pg.No: 633)",
              "Amiodarone *** (Jul 23;Feb 11;Aug 08) (Pg.No: 577)",
              "Anti-hypertensives in Pregnancy *** (Jul 23;Aug 14;Feb 05) (Pg.No: 617)",
              "Direct Oral Anti-coagulants *** (Aug 22;Sep 21;Feb 05) (Pg.No: 667)",
              "Myocardial Infarction *** (Feb 14;Aug 13;Aug 10) (Pg.No: 602)",
              "Adenosine ** (Feb 20;Aug 13) (Pg.No: 581)",
              "Amlodipine ** (Feb 18;Apr 01) (Pg.No: 595)",
              "Angiotensin Receptor Blockers (ARBs) ** (Feb 13;Aug 10) (Pg.No: 535)",
              "Atorvastatin ** (Feb 10;Feb 08) (Pg.No: 685)",
              "Cardiac Glycosides ** (Aug 19;Aug 09) (Pg.No: 556)",
              "Glycoprotein IIb/IIIa Receptor Antagonist ** (Feb 18;Aug 13) (Pg.No: 679)",
              "Losartan ** (Aug 14;Feb 07) (Pg.No: 535)",
              "Nitrates ** (Aug 08;Aug 05) (Pg.No: 585)",
              "Renin Angiotensin System (RAS) ** (Jul 23;Aug 13) (Pg.No: 524)",
              "Beta Blockers as Anti-hypertensives (Aug 09) (Pg.No: 609)",
              "Carvedilol (Feb 10) (Pg.No: 610)",
              "Class III Anti-arrhythmic Drugs (Aug 14) (Pg.No: 577)",
              "Direct Renin Inhibitor (Feb 23) (Pg.No: 538)",
              "Eprosartan (Feb 22) (Pg.No: 537)",
              "Epsilon Amino-Caproic Acid (Aug 11) (Pg.No: 676)",
              "Erythrocyte Maturation Factor (Feb 22) (Pg.No: 652)",
              "Erythropoietin (Feb 13) (Pg.No: 657)",
              "Glyceryl Trinitrate (Feb 12) (Pg.No: 588)",
              "Heparin Antagonist (Aug 12) (Pg.No: 666)",
              "Hypertensive Emergencies (Mar 22) (Pg.No: 618)",
              "Ranolazine (Feb 19) (Pg.No: 600)",
              "Sodium Nitroprusside (Feb 16) (Pg.No: 613)",
              "Venodilators (Feb 13) (Pg.No: 612)"
            ]
          }
        }
      }
    }
  }
};
